Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5771-5781

  Heeger, Peter S ^a   Forsthuber, Thomas ^a   Shive, Carey ^a   Biekert, Earla ^a   Genain, Claude ^b   Hofstetter, Harald H ^a   Karulin, Alexey ^a   Lehmann, Paul V ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; FREUND ADJUVANT; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; IMMUNOLOGICAL TOLERANCE; INTERSTITIAL NEPHRITIS; MALE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034119903     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5771     Document Type: Article

References (77)

1. Rauch, H. C., E. R. Einstein, J. Csejtey, and W. J. Davis. 1968. Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis. Immunochemistry 5:567.
2. Alvord, E. C., S. Hruby, K. Hughes, C. M. Shaw, and M. W. Kies. 1969. Comparisons of organ-specific antigens of the central nervous system. Int. Arch. Allergy Appl. Immunol. 36:276.
3. Driscoll, B. F., M. W. Kies, and E. C. Alvord, Jr. 1976. Protection against experimental allergic encephalomyelitis with peptides derived from myelin basic protein: presence of intact encephalitogenic site is essential. J. Immunoi. 117:110.
4. Swierkosz, J. E., and R. H. Swanborg. 1975. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immunol. 115:631.
5. Bernard, C. C. 1977. Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clin. Exp. Immunol. 29:100.
6. Swierkosz, J. E., and R. H. Swanborg. 1977. Immunoregulation of experimental allergic encephalomyelitis; conditions for induction of suppressor cells and analysis of mechanism. J. Immunol. 119:1501.
7. Bloom, B. R., P. Salgame, and B. Diamond. 1992. Revisiting and revising suppressor T cells. Immunol. Today 13:131.
8. Clayton, J. P., G. M. Gammon, D. G. Ando, D. H. Kono, L. Hood, and E. E. Sercarz. 1989. Peptide-specific prevention of experimental allergic encephalomyelitis: neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 169:1681.
9. Gammon, G. M., A. Oki, N. Shastri, and E. E. Sercarz. 1986. Induction of tolerance to one determinant on a synthetic peptide does not affect the response to a second linked determinant: implications for the mechanism of neonatal tolerance induction. J. Exp. Med. 164:667.
10. Vidard, L., L. J. Colarusso, and B. Benacerraf. 1995. Specific T-cell tolerance may reflect selective activation of lymphokine synthesis. Proc. Natl. Acad. Sci. USA 92:2259.
11. Kearney, E. R., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
12. Wang, R., Y. Wang-Zhu, C. R. Gabaglia, K. Kimachi, and H. M. Grey. 1999. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope. J. Exp. Med. 190:983.
13. Janeway, C. A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13:11.
14. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
15. Freund, J. 1956. The mode of action of immunologic adjuvants. Adv. Tuberc. Res. 7:130.
16. Herbert, W. J. 1968. The mode of action of mineral-oil emulsion adjuvants on antibody production in mice. Immunology 14:301.
17. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strain, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
18. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728.
19. Yip, H. C., A. Y. Karulin, M. Tary-Lehmann, M. D. Hesse, H. Radeke, P. S. Heeger, R. P. Trezza, F. P. Heinzel, T. Forsthuber, and P. V. Lehmann. 1999. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162:3942.
20. Karulin, A., M. Hesse, M. Tary-Lehmann, and P. Lehmann. 2000. Single cytokine producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164:1862.
21. + T cells in the thymus. Cell 73:1041.
22. Ashton-Rickardt, P. G., and S. Tonegawa. 1994. A differential-avidity model for T-cell selection. Immunol. Today 15:362.
23. Targoni, O. S., and P. V. Lehmann. 1998, Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:2055.
24. Lehmann, P. V., O. S. Targoni, and T. G. Forsthuber. 1998. Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol. Rev. 164:53.
25. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1579.
26. + T cells. J. Exp. Med. 182:1591.
27. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
28. Swain, S. L. 1994. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1:543.
29. + T cell depletion and T helper cell type 1-selective cytokine therapy. J. Exp. Med. 189:1895.
30. Finkelman, F. D. 1995. Relationships among antigen presentation, cylokines, immune deviation, and autoimmune disease. J. Exp. Med. 182:279.
31. Nicholson, L. B., and V. K. Kuchroo. 1996. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8:837.
32. Rocken, M., M. Racke, and E. M. Shevach. 1996. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 17:225.
33. Pakala, S. V., M. O. Kurrer, and J. D. Katz. 1997. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:299.
34. Khoruts, A., S. D. Miller, and M. K. Jenkins. 1995. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Thl cells. J. Immunol. 155:5011.
35. Lafaille, J. J., F. V. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
36. Van der Veen, R. C., and S. A. Stohlman. 1993. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:213.
37. Chen, C., and N. Nabavi. 1994. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1:147.
38. Cua, D. J., D. R. Hinton, and S. A. Stohlman. 1995. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of autoimmune disease. J. Immunol. 155:4052.
39. Dietzschold, B. 1993. Antibody-mediated clearance of viruses from the mammalian central nervous system. Trends Microbiol. 1:63.
40. Westland, K. W., J. D. Pollard, S. Sander, J. G. Bonner, C. Linington, and J. G. McLeod. 1999. Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies. Brain 122:1283.
41. Kroepfl, J. F., L. R. Viise, A. J. Charron, C. Linington, and M. V. Gardinier. 1996. Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J. Neurochem. 67:2219.
42. Brehm, U., S. J. Piddlesden, M. V. Gardinier, and C. Linington. 1999. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 97:9.
43. Stefferl, A., U. Brehm, M. Storch, D. Lambracht-Washington, C. Bourquin, K. Wonigeit, H. Lassmann, and C. Linington. 1999. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J. Immunol. 163:40.
44. Genain, C. P., K. Abel, N. Belmar, F. Villinger, D. P. Rosenberg, C. Linington, C. S. Raine, and S. L. Hauser. 1996. Late complications of immune deviation therapy in a nonhuman primate. Science 274:2054.
45. Blanas, E., F. R. Carbone, J. Allison, J. F. Miller, and W. R. Heath. 1996. Induction of autoimmune diabetes by oral administration of autoantigen. Science 274:1707.
46. Lenz, D. C., N. A. Wolf, and R. H. Swanborg. 1999. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 163:1763.
47. Heeger, P. S., W. E. Smoyer, T. Saad, S. Albert, C. J. Kelly, and E. G. Neilson. 1994. Molecular analysis of the helper T cell response in murine interstitial nephritis: T cells recognizing an immunodominant epitope use multiple T cell receptor Vβ genes with similarities across CDR3. J. Clin. Invest. 94:2084.
48. Neilson, E. G., M. J. Sun, C. J. Kelly, W. H. Hines, T. P. Haverty, M. D. Clayman, and N. E. Cooke. 1991. Molecular characterization of a major nephritogenic domain in the autoantigen of anti-tubular basement membrane disease. Proc. Natl. Acad. Sci. USA 88:2006.
49. Hines, W. H., R. A. Mann, C. J. Kelly, and E. G. Neilson. 1990. Murine interstitial nephritis. IX. Induction of the nephritogenic effector T cell repertoire with an antigen-specific T cell cytokine. J. Immunol 144:75.
50. + suppressor T cells which are antigen-specific and inhibit the expression of disease. J. Immunol. 136:903.
51. Pender, M. P., K. B. Nguyen, P. A. McCombe, and J. F. Kerr. 1991. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104:81.
52. Bauer, J., M. Bradl, W. F. Hickley, S. Forss-Petter, H. Breitschopf, C. Linington, H. Wekerle, and H. Lassmann. 1998. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 153:715.
53. Lehmann, P. V. 1998. The fate of T cells in the brain: veni, vidi, vici and veni, mori. Am. J. Pathol. 153:677.
54. Deibler, G. E., R. E. Martenson, and M. W. Kies. 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:139.
55. Amor, S., N. Groome, C. Linington, M. M. Morris, K. Dornmair, M. V. Gardinier, J. M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349.
56. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.
57. Matesic, D., P. V. Lehmann, and P. S. Heeger. 1998. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 65:906.
58. Coffman, R. L., D. A. Lebman, and P. Rothman. 1993. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54:229.
59. Finkelman, F. D., I. M. Katona, J. F. Urban, Jr., C. M. Snapper, J. Ohara, and W. E. Paul. 1986. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. USA 83:9675.
60. + T cells: IL 5 is essential for induction of antigen-specific antibody responses by TH2 but not TH1 clones. Eur. J. Immunol. 20:2219.
61. Kelso, A. 1995. Th1 and Th2 subsets: paradigms lost? Immunol. Today 16:374.
62. + T-cell phenotype development. Proc. Natl. Acad. Sci. USA 92:7565.
63. Jung, T., U. Schauer, C. Rieger, K. Wagner, K. Einsle, C. Neumann, and C. Heusser. 1995. Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur. J. Immunol. 25:2413.
64. + T cell subset. Eur. J. Immunol. 28:3630.
65. + lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice. Int. Immunol. 10:1853.
66. McKenzie, G. J., P. G. Fallon, C. L. Emson, R. K. Grencis, and A. N. McKenzie. 1999. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189:1565.
67. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54:1.
68. Litzenburger, T., R. Fassler, J. Bauer, H. Lassmann, C. Linington, H. Wekerle, and A. Iglesias. 1998. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188:169.
69. Neuberger, M. S., and K. Rajewsky. 1981. Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11:1012.
70. Bruggemann, M., C. Teale, M. Clark, C. Bindon, and H. Waldmann. 1989. A matched set of rat/mouse chimeric antibodies: identification and biological properties of rat H chain constant regions μ, γ1, γ2a, γ2b, γ2c, ∈, and α. J. Immunol. 142:3145.
71. Ehrlich, P. 1900. On immunity with special reference to cell life. Proc. R. Soc. London Biol. 66:424.
72. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
73. Jenkins, M. K., D. M. Pardoll, J. Mizuguchi, H. Quill, and R. H. Schwartz. 1987. T-cell unresponsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state. Immunol. Rev. 95:113.
74. Tian, J., P. V. Lehmann, and D. L. Kaufman. 1997. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186: 2039.
75. Falcone, M., and B. R. Bloom. 1997. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:901.
76. Hancock, W. W., R. Buelow, M. H. Sayegh, and L. A. Turka. 1998. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoplotic genes. Nat. Med. 4:1392.
77. Ding, M., M. Zhang, J. L. Wong, N. E. Rogers, L. J. Ignarro, and R. R. Voskuhl. 1998. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160:2560.